Growthplane Information

Growthplane helps growth-stage MedTech and healthcare AI companies close that gap before they spend the next round scaling something that has not yet earned repeatable adoption. Early clinical traction, a clearance, or a first site can look like the hard part is over. In MedTech it usually is not. Hospitals, Value Analysis Committees, and payers do not buy the way a departmental software buyer does. Fit has to hold clinically, economically, and operationally, across several stakeholders, or expansion stalls. We work with founder-led companies that already have a product and early validation, and with the investors who back them. The work is to determine whether the PMF is real enough to scale, where it is thin, and what evidence and commercial foundations have to be in place before GTM spend starts compounding waste. That includes post-pilot go-to-market choices, partnership sequencing, VAC and reimbursement readiness, and the operating discipline that keeps fit from eroding as the company grows.